HealthiosXchange is a Crowdfunding Portal launched by Healthios, a Chicago-Based healthcare investment bank. HealthiosXchange serves the interests of Strategics (large pharma/biotech) seeking to identify, research, and partner with promising emerging growth healthcare companies. By joining a global network of successful executives, thought leaders, entrepreneurs and fellow investors, members of the HealthiosXchange
("H/X") become part of an elite group of passionate, intelligent and imaginative individuals searching for both superior returns and a chance to establish a legacy that will have a meaningful impact on the world.
HealthiosXchange – Assisting Strategics with "Perfecting the Transaction Process"
Enhance Exposure to Innovation.
The H/X offers premier access to the broadest range of healthcare opportunities: from the most innovative start-ups to well-established emerging growth companies. By employing sophisticated screening and organization techniques, the H/X can showcase an infinite universe of Emerging Growth healthcare companies.
Data Gateway: Sector segmentation; financing activity; H/X Scoring; Trending.
The H/X comprises the broadest listing of emerging growth healthcare companies of any investment marketplace. Currently representing more than 1,700 companies in (94) market segments, the H/X is able to generate more than 500,000 data points on the most innovative opportunities.
Increase Breadth Of Growth, Partnership & Acquisition Opportunities.
Since 2010, the 1,700 EGC’s listed on the H/X consummated (362) financing and strategic transactions. As a complement to their own Business Development activities, the H/X will ensure direct and continuous access to the most important growth opportunities in the global healthcare industry.
Track Clinical, Regulatory, Organizational, Strategic Progress.
The H/X monitors the progress of the emerging growth healthcare community on a continuous basis, through a consolidation of more than (100) "real-time" news feeds and H/X investment research, as well as through updates to H/X Company profiles. This provides the most effective and reliable perspective on progress.
Perform Detailed, Company-by-Company Assessment in Efficient, Discrete Manner.
The H/X Company Homepage is the most reliable representation of the strategic and investment thesis of an emerging growth healthcare company. It allows investors and strategic partners to assess positioning, benchmark performance, and measure progress using the most relevant information in a flexible – yet highly relevant – manner.
Expand Relationships & Affinity with High-Priority Targets.
As investors and strategic partners seek to fortify their relationships with the most important emerging growth companies, the H/X allows for those relationships to be nurtured directly, discretely and in a fashion perfectly suited for the circumstances.
If you are a Large Pharma/Biotech ("Strategic") and interested in learning more about H/X, please email me at sjordan@healthios.com